Abstract 3276: Clinical PK, PD and safety analysis of a phase I clinical trial of DT-9081, an EP4R-antagonist, for RP2D determination in patients with advanced solid tumours
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Christophe Le Tourneau, Zahra Castel-Ajgal, Jean-Pascal Machiels, Rachel Galot, Nuria Kotecki, Christiane Jungels, Jean-Pierre Delord, Iphigenie Korakis, Anne-Laure Blayo, Lola Lecru, Thibaut Brugat, Stephan Schann, Nathalie Lenne, Samira El-Farouk, Claire Jouffroy-Zeller, Anne Quesnel, Carolina Duarte, Karim Taamma
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409688876